Alkhayal Abdullah, Alfraidi Omar Badr, Alhussaini Abdulaziz, Alsaghyir Abdullah, Alqobaisi Ali I, Alsaikhan Bader, Alathel Abdulaziz, Noureldin Yasser A
Division of Urology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Department of Urology, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Urol Ann. 2025 Apr-Jun;17(2):92-96. doi: 10.4103/ua.ua_107_23. Epub 2025 Apr 17.
Transurethral resection of the prostate (TURP) remains the gold standard surgical approach for benign prostatic obstruction. Our aim in this study was to assess factors affecting failure of the first trial of void (TOV) post-TURP.
This was a retrospective study that included all patients who underwent TURP from January 2016 to January 2020 at our tertiary care endourology center. Patients and prostate characteristics were collected. Patients who developed complications intraoperatively were excluded. Multivariable analysis was performed to identify factors which predict the failure of the first TOV. Furthermore, predictors of acute urinary retention within 30 days from TURP were assessed.
A total of 263 patients who underwent TURP were collected. The mean age was 72.76 ± 8.65 years. Patients with diabetes mellitus (DM) were 50.2% and hypertension were 64.6%. The majority of patients, 78%, had a history of retention before TURP and the most commonly used medication before the operation was alpha-blocker. On univariate analysis, patients who were on Foley's catheter and patients who had type II DM were associated with significantly higher failure of first TOV (15.2% vs. 5.9%; = 0.031) and (18.2% vs. 6.1%; = 0.003). However, the multivariable analysis revealed that only patients with type II DM had six times (odds ratios: 5.837; = 0.006) higher chance to fail the first TOV.
Type II DM was associated with six times increase in the incidence of failure of the first TOV following TURP.
经尿道前列腺切除术（TURP）仍然是治疗良性前列腺梗阻的金标准手术方法。本研究的目的是评估影响TURP术后首次排尿试验（TOV）失败的因素。
这是一项回顾性研究，纳入了2016年1月至2020年1月在我们的三级医疗泌尿内镜中心接受TURP的所有患者。收集患者和前列腺的特征。排除术中出现并发症的患者。进行多变量分析以确定预测首次TOV失败的因素。此外，评估了TURP后30天内急性尿潴留的预测因素。
共收集了263例接受TURP的患者。平均年龄为72.76±8.65岁。糖尿病（DM）患者占50.2%，高血压患者占64.6%。大多数患者（78%）在TURP前有尿潴留史,术前最常用的药物是α受体阻滞剂。单变量分析显示，留置 Foley 导尿管的患者和患有 II 型糖尿病的患者首次TOV失败率显著更高（15.2%对5.9%；P = 0.031）以及（18.2%对6.1%；P = 0.003）。然而，多变量分析显示，只有II型糖尿病患者首次TOV失败的几率高出六倍（比值比：5.837；P = 0.006）。
II型糖尿病与TURP术后首次TOV失败发生率增加六倍有关。
